NEW ORLEANS, Sept. 29, 2017 -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 10, 2017 to file lead plaintiff applications in a securities class action lawsuit against TransDigm Group Incorporated (NYSE:TDG), if they purchased the Company’s securities between May 10, 2016 and March 21, 2017, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of Ohio.
Get Help
TransDigm investors should visit us at https://www.claimsfiler.com/cases/view-transdigm-group-inc-securities-litigation or call to speak to our claim center toll-free at (844) 367-9658.
About the Lawsuit
TransDigm and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
The alleged false and misleading statements and omissions include, but are not limited to, that: (i) the Company’s unethical and/or illegal business practices artificially inflated growth and profitability and was not sustainable; (ii) the Company utilized shell distributors to make noncompetitive government bids appear competitive; (iii) the Company’s subsidiary entities failed to list it as a parent and/or controlling entity when submitting for government bids; and (iv) as a result of the foregoing, TransDigm’s financial statements were materially false and misleading at all relevant times.
About ClaimsFiler
ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. ClaimsFiler's team of experts monitor the securities class action landscape and cull information from a variety of sources to ensure comprehensive coverage across a broad range of financial instruments.
To learn more about ClaimsFiler, visit www.claimsfiler.com.


Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Anta Sports Expands Global Footprint With Strategic Puma Stake
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Samsung Electronics Shares Jump on HBM4 Mass Production Report
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 



